IP Library Granted Patent US 9,751,950
Granted Patent B2
US 9,751,950 · App. 14/725,873 · Granted Sep 5, 2017

Methods of reducing skeletal muscle loss using an antibody against Fn14

Inventor: Ashok Kumar (Louisville, KY)
Assignee: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
C07K16/2878C07K16/2875A61K2039/505C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,751,950
App. No.
14/725,873
Granted
Sep 5, 2017
Kind
B2
Abstract

The invention provides methods for preventing loss and augmenting regeneration of skeletal muscle by decreasing the activity of the TWEAK/Fn14 system.

Claims (15)

1. A method for reducing loss of skeletal muscle in a patient, comprising administering to a patient having a battlefield injury, an accidental injury, anorexia or diabetes a therapeutically effective amount of an agent that decreases the activity of the TWEAK/Fn14 system so as to reduce the loss of skeletal muscle, wherein the agent is an Fn14 neutralizing antibody that blocks Fn14 activity.

2. A method for reducing loss of force production by skeletal muscle in a patient, comprising administering to a patient having a battlefield injury, an accidental injury, anorexia or diabetes a therapeutically effective amount of an agent that decreases the activity of the TWEAK/Fn14 system so as to reduce toss of force production by the skeletal muscle, wherein the agent is an Fn14 neutralizing antibody that blocks Fn14 activity.

3. The method of claim 1 , wherein the patient has a battlefield injury.

4. The method of claim 1 , wherein the patient does not have cachexia.

5. The method of claim 1 , wherein the patient has an accidental injury.

6. The method of claim 1 , wherein the patient has diabetes.

7. The method of claim 1 , wherein the patient has anorexia.

8. The method of claim 1 , wherein the skeletal muscle is a soleus, tibial anteriors, gastrocnemius, EDL, diaphragm, biceps, triceps, quadriceps, facial, tongue, or abdominal muscle.

9. The method of claim 1 , wherein the administration of the therapeutically effective amount of an agent that decreases the activity of the TWEAK/Fn14 system also reduces the loss of force production by the skeletal muscle.

10. The method of claim 2 , wherein the patent has a battlefield injury.

11. The method of claim 2 , wherein the patient does not have cachexia.

12. The method of claim 2 , wherein the patient has an accidental injury.

13. The method of claim 2 , wherein die patient has diabetes.

14. The method of claim 2 , wherein the patient has anorexia.

15. The method of claim 2 , wherein the skeletal muscle is a soleus, tibial anteriors, gastrocnemius, EDL, diaphragm, biceps, triceps, quadriceps, facial, tongue, or abdominal muscle.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 8, 2018
From: UNIVERSITY OF LOUISVILLE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046327/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2016
From: KUMAR, ASHOK
To: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
Reel/Frame 038452/0904 →
Continuity (3)
Division 13576838
Provisional Application 61301454 · Feb 4, 2010
Related Publication 20160096896A1 · Apr 7, 2016